Literature DB >> 11750206

General medical and psychiatric comorbidity among HIV-infected veterans in the post-HAART era.

A M Kilbourne1, A C Justice, L Rabeneck, M Rodriguez-Barradas, S Weissman.   

Abstract

We examined the prevalence of HIV, general medical, and psychiatric comorbidities by age based on a recent multisite cohort of HIV infected veterans receiving care: the Veterans with HIV/AIDS 3 Site Study (VACS 3). VACS 3 includes 881 adult patients with HIV infection enrolled between June 1999 and July 2000. Providers reported their patients' CDC-defined HIV comorbidities, general medical comorbidities (based on Duke and Charlson comorbidity scales), and psychiatric comorbidity. Mean age of participants was 49 years and 54% were African-American. The most common HIV comorbidities were oral candidiasis (21%), peripheral neuropathy (16%), and herpes zoster (16%). The most common general medical comorbidities included chemical hepatitis (53%), hypertension (24%), and hyperlipidemia (17%). The mean number of HIV and general medical comorbidities experienced by patients were respectively 1.1 and 1.4 (P < .001). Older (> or = 50 years) HIV-infected patients experienced a greater number of general medical comorbidities than those < 50 years (respectively 1.7 versus 1.2, P < .001). There was no significant difference in mean HIV comorbidity number by age. Based on patient report, 46% had significant depressive symptoms (> or = 10 on 10-item CES-D) and 21% reported at-risk drinking (> or = 8 on AUDIT). Providers reported 32% of patients had anxiety, 4% mania, 4% schizophrenia, and 11% cognitive impairment/dementia. General medical and psychiatric comorbidities constituted a higher disease burden for HIV-infected veterans than HIV comorbidities. Whether these comorbidities are due to antiretroviral drug toxicity or are age or lifestyle-associated conditions, the substantial prevalence of these "non-HIV" comorbidities suggest an important role for general medical and psychiatric management of HIV-infected patients.

Entities:  

Mesh:

Year:  2001        PMID: 11750206     DOI: 10.1016/s0895-4356(01)00443-7

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  47 in total

Review 1.  Neuropsychiatric complications of aging with HIV.

Authors:  Crystal C Watkins; Glenn J Treisman
Journal:  J Neurovirol       Date:  2012-05-30       Impact factor: 2.643

Review 2.  Drug treatment of depression in HIV-positive patients : safety considerations.

Authors:  Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 3.  Safety considerations in drug treatment of depression in HIV-positive patients: an updated review.

Authors:  Crystal C Watkins; Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

4.  Coping styles and illicit drug use in older adults with HIV/AIDS.

Authors:  Linda M Skalski; Kathleen J Sikkema; Timothy G Heckman; Christina S Meade
Journal:  Psychol Addict Behav       Date:  2013-02-25

5.  Under-documentation of psychiatric diagnoses among persons living with HIV in electronic medical records.

Authors:  Lily A Brown; Wenting Mu; Jesse McCann; Stephen Durborow; Michael B Blank
Journal:  AIDS Care       Date:  2020-01-13

6.  Patterns of drug use and abuse among aging adults with and without HIV: a latent class analysis of a US Veteran cohort.

Authors:  Traci C Green; Trace Kershaw; Haiqun Lin; Robert Heimer; Joseph L Goulet; Kevin L Kraemer; Adam J Gordon; Steve A Maisto; Nancy L Day; Kendall Bryant; David A Fiellin; Amy C Justice
Journal:  Drug Alcohol Depend       Date:  2010-04-15       Impact factor: 4.492

7.  The impact of depressive symptoms on patient-provider communication in HIV care.

Authors:  Charles R Jonassaint; Carlton Haywood; Philip Todd Korthuis; Lisa A Cooper; Somnath Saha; Victoria Sharp; Jonathon Cohn; Richard D Moore; Mary Catherine Beach
Journal:  AIDS Care       Date:  2013-01-15

Review 8.  Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms.

Authors:  Victor G Valcour; Cecilia M Shikuma; Michael R Watters; Ned C Sacktor
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

9.  HIV infection and the risk of diabetes mellitus.

Authors:  Adeel A Butt; Kathleen McGinnis; Maria C Rodriguez-Barradas; Stephen Crystal; Michael Simberkoff; Matthew Bidwell Goetz; David Leaf; Amy C Justice
Journal:  AIDS       Date:  2009-06-19       Impact factor: 4.177

10.  Prevalence and patient awareness of medical comorbidities in an urban AIDS clinic.

Authors:  Jeffrey J Weiss; Georgina Osorio; Elizabeth Ryan; Sue M Marcus; Dawn A Fishbein
Journal:  AIDS Patient Care STDS       Date:  2010-01       Impact factor: 5.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.